The company is stopping work on its software program called Verily Value Suite. Originally known as Google Life Sciences, the company has focused on digital health, including rolling out an online diabetes clinic and an online tool to connect research participants with studies.
In September, the company received $1 billion in funding from Alphabet.
“We are making changes that refine our strategy, prioritize our product portfolio and simplify our operating model,” Verily CEO Stephen Gillett wrote in an email to employees. “We will advance fewer initiatives with greater resources.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
